Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Quantum-Si Incorporated has 7 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 7 distinct examiners and 7 distinct art units, indicating complete dispersion across the active examination workload. No examiner or art-unit concentration is shown.
EIX, EMILY FAY is the busiest examiner, with 1 pending matter. That assignment is consistent with the broader distribution, so counsel should avoid relying on a single examiner strategy for the portfolio.
Portfolio management should emphasize matter-level deadlines, art-unit-specific technical positioning, and consistency checks across claim drafting. Similar subject matter may still require different responses because the available data does not identify common rejections or shared procedural histories.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (43%) |
| §103 only | 1 (14%) |
| Double-patenting + other | 2 (29%) |
| Multi-statute (no §101) | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EIX, EMILY FAY | 1 | 45.9% | +73.9% |
| VARADARAJ, ARCHANA | 1 | 57.1% | +42.9% |
| PHAM, KHAI QUYNH TIEN | 1 | 0.0% | +0.0% |
| CROW, ROBERT THOMAS | 1 | 41.4% | +32.7% |
| JORDAN, ANDREW | 1 | 44.4% | +17.3% |
| GRAY, JESSICA | 1 | 0.0% | +0.0% |
| KRIANGCHAIVECH, KETTIP | 1 | 18.6% | +27.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18335963 | METHODS AND COMPOSITIONS FOR PROTEIN FINGERPRINTING | PHAM, KHAI QUYNH TIEN | 12d |
| 18365185 | COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS | VARADARAJ, ARCHANA | — |
| 17300940 | Molecular Barcode Analysis by Single-Molecule Kinetics | GRAY, JESSICA | — |
| 16686028 | METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING | KRIANGCHAIVECH, KETTIP | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17555323 | OPTICAL REJECTION PHOTONIC STRUCTURES | JORDAN, ANDREW | 66d overdue |
| 18491719 | POLYPEPTIDE CLEAVING REAGENTS AND USES THEREOF | EIX, EMILY FAY | — |
| 18365185 | COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS | VARADARAJ, ARCHANA | — |
| 18188122 | HIGH INTENSITY LABELED REACTANT COMPOSITIONS AND METHODS FOR SEQUENCING | CROW, ROBERT THOMAS | — |
| 16686028 | METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING | KRIANGCHAIVECH, KETTIP | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1658 | 1 |
| 1684 | 1 |
| 1683 | 1 |
| 2874 | 1 |
| 1682 | 1 |
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18491719 | POLYPEPTIDE CLEAVING REAGENTS AND USES THEREOF | EIX, EMILY FAY | 1653 | §103§112DP | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18365185 | COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS | VARADARAJ, ARCHANA | 1658 | §101§102§103§112DP | Non-Final OA | — | Pending | Aug 03, 2023 |
| 18335963 | METHODS AND COMPOSITIONS FOR PROTEIN FINGERPRINTING | PHAM, KHAI QUYNH TIEN | 1684 | §102§103 | Non-Final OA | 12d | Pending | Jun 15, 2023 |
| 18188122 | HIGH INTENSITY LABELED REACTANT COMPOSITIONS AND METHODS FOR SEQUENCING | CROW, ROBERT THOMAS | 1683 | §102§103DP | Non-Final OA | — | Pending | Mar 22, 2023 |
| 17555323 | OPTICAL REJECTION PHOTONIC STRUCTURES | JORDAN, ANDREW | 2874 | §103 | Final Rejection | 66d overdue | Pending | Dec 17, 2021 |
| 17300940 | Molecular Barcode Analysis by Single-Molecule Kinetics | GRAY, JESSICA | 1682 | §101§103 | Final Rejection | — | Pending | Dec 15, 2021 |
| 16686028 | METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING | KRIANGCHAIVECH, KETTIP | 1686 | §101§103DP | Final Rejection | — | Pending | Nov 15, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialQuantum-Si Incorporated has 7 pending office actions as of November 2026, spread across 7 art units and 7 examiners.
Emily Fay Eix has the most, with 1 of Quantum-Si Incorporated's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.